• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
Cognitive Function and Ageing Studies

Cognitive Function and Ageing Studies

CFAS

  • Home
  • MRC CFAS
    • Study Design
    • Study Documentation
    • Key Findings
    • Data
  • CFAS II
    • Study Design
    • Study Documentation
    • Key Findings
    • Data
  • CFAS Wales
    • Study Design
    • Study Documentation
    • Data
  • Key Findings
  • Publications
  • Research Team
    • Research Degrees
    • Alzheimer’s Society Doctoral Training Centre
  • Participant Info
    • How is my data used?
    • Change of Address or moving?
    • Mind over Matter
  • Internal

Welcome to CFAS

 

What are the Cognitive Function and Ageing Studies?Notts1

The Cognitive Function and Ageing Studies (CFAS) are population based studies of individuals aged 65 and over living in the community, including institutions. CFAS is the only large multi-centred, population-based study in the UK that has reached sufficient maturity. There are three main studies within the CFAS group;  MRC CFAS, the original study which began in 1989, the comparison study CFAS II (2008 onward) and CFAS Wales (2011).                                                                                                                                                                                                   

What are we investigating? 

The initial aims of CFAS were to investigate dementia and cognitive decline in a representative sample of more than 18,000 people aged over 65 years. To describe the service needs of dementia sufferers and the degree of disability suffered. To find out which factors increase the risk of someone developing dementia, and to investigate the different diseases that cause dementia and how quickly dementia progresses.
  
 

The value of CFAS

Since 1989 life expectancy in the UK and across the globe has increased with dramatic changes in some major chronic diseases.  Symptomatic treatments for dementia, specifically its most commonly diagnosed form, Alzheimer’s Disease has been adopted and there is major research in the area of early detection diagnostics and novel disease modifying therapies.
 
Having provided estimations of dementia occurrence for the UK from its first studies CFAS was increasingly asked to provide evidence on generational change in dementia, cognition and life expectancy by the government and the public, leading to its daughter study, CFAS II.  The use of CFAS in public policy decisions and in long term projections is now well established.  In addition CFAS research is emerging issues such as cognitive screening, mild cognitive impairment (MCI) and early detection.  It has a wealth of findings for comparison with the new cohort (CFAS II) data.

Primary Sidebar

Log In

Please log into the site.

Latest News

  • CFAS DTC – 1st Annual Scientific Meeting
  • Alzheimer’s Society Research Conference 2016 – poster abstracts
  • CFAS release updated dementia incidence figures
  • Alzheimer’s Society research conference- Poster presentation
  • EPAD

CFAS Administration Centre

Institute of Public Health
Forvie Site
Robinson Way
Cambridge
CB2 0SR
01223 330312

Copyright © 2023 · CFAS · Send comments to Emily Zhao

Copyright © 2023 · Genesis Sample on Genesis Framework · WordPress · Log in

  • Home
  • MRC CFAS
  • CFAS II
  • CFAS Wales
  • Key Findings
  • Publications
  • Research Team
  • Participant Info
  • Internal